The hepcidin–FPN axis seems to play a role in the modulation of the inflammation and polarization of macrophages present in atherosclerotic plaques, but the effects are different in the various stages of the long process of atherosclerosis progression from early lesions to advanced plaques. This evidence concerns the gene SLC40A1 and atherosclerosis.